SCHEMBL30810313

SCHEMBL30810313

COC(=O)c1cc(Cl)cc(CO)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
ABL1 P00519 1/20 0.41
SERPINH1 P50454 1/20 0.41
GALK1 P51570 1/20 0.41
POLB P06746 2/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
ACLY P53396 1/20 0.40
GAA P10253 2/20 0.40
CYP2C19 P33261 1/20 0.40
USP2 O75604 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612138 1.00 KDM4E (0.48) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL30810287 0.89 KDM4E (0.45) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL30810413 0.88 KMT2A (0.43) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL19612141 0.86 KDM4E (0.43) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL30810239 0.86 KDM4E (0.43) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL522218 0.83 SLC6A4 (0.45) KDM4EALDH1A1HPGDSLC6A4SLC6A3
SCHEMBL19612171 0.83 ALDH1A1 (0.41) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL30810291 0.83 ABL1 (0.42) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL19612155 0.83 ABL1 (0.42) KDM4EALDH1A1HPGDNPSR1SLC6A4
SCHEMBL23796582 0.82 KDM4E (0.47) KDM4EALDH1A1HPGDNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed